McKesson Investor Attys Get $35M For $141M Price Fix Deal

By Henrik Nilsson

Robbins Geller Rudman & Dowd LLP attorneys who represent a class of McKesson investors will receive $35 million in fees from a $141 million settlement for their work on litigation alleging the company made false assertions concerning a drug price-fixing scheme, according to an order issued in California federal court on Friday.

 2 documents attached | Read full article » | Save to favorites »